Microbiological and HPLC analysis of miconazole in skin, serum and phase-solubility studies

Journal of Clinical Pharmacy and Therapeutics

Volumn 24, Issue 6, 1999, Pages 445-450

  Puranajoti, P ^a   Kasina, R ^a   Tenjarla, S ^a,b  

^a MERCER UNIVERSITY   (United States)

^b SOUTHERN RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MICONAZOLE;

AGAR GEL DIFFUSION; ANALYTIC METHOD; ANIMAL EXPERIMENT; ARTICLE; BIOASSAY; CALIBRATION; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG ISOLATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INTERMETHOD COMPARISON; MOUSE; NONHUMAN; SKIN; SKIN PERMEABILITY;

ANIMALS; BIOLOGICAL ASSAY; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CYCLODEXTRINS; DRUG STABILITY; MICE; MICE, INBRED HRS; MICONAZOLE; MICROBIOLOGICAL TECHNIQUES; PERMEABILITY; SACCHAROMYCES CEREVISIAE; SENSITIVITY AND SPECIFICITY; SKIN; SOLUBILITY;

EID: 0033371340     PISSN: 02694727     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2710.1999.00251.x     Document Type: Article

References (15)

1. 1. Jawetz E. (1992) Antifungal agents. In: Katzung BG, Bertram G. eds. Basic and Clinical Pharmacology, 5th edn. Norwalk, Connecticut: Appleton & Large, 667-673.
2. 2. Martindale W, et al. (1993) In: Reynolds EF, Parfitt K, Parsons AV, Sweetman SC. eds. The Extra Pharmacopoeia/ Martindale, 30th edn. London: Pharmaceutical Press, 315-332.
3. 3. Bennett JE, et al. (1993) Antifungal Agents. In: Gilman AG, Goodman LS, Rall TW, Nies AS, Taylor P, eds. The Pharmacological Basis of Therapeutics, 8th edn. New York: McGraw-Hill Inc, 1165-1181.
4. 4. Saag SM, Dismukes EM. (1988) Azole antifungal agents: emphasis on new triazoles. Antimicrobial Agents and Chemotherapy, 32, 1-8.
5. 5. Pershing KL, Corlett J, Jorgensen C. (1994) In vivo pharmacokinetics and pharmacodynamics of topical ketoconazole and miconazole in human stratum corneum Antimicrobial Agents and Chemotherapy, 3, 890-8 99 5.
6. 6. Higuchi T, Connors A. (1965) Phase-solubility techniques. Advanced Analytical Chemical Instrumentation. 4, 117-211.
7. 7. Cavrini V, Pietra Di MA & Raggi AM (1982) High-pressure liquid chromatographic (HPLC) analysis of imidazole antifungals in commercial dosage forms. International Journal of Pharmaceutics, 10, 119-124.
8. 8. U.S. Pharmacopeial Convention (1990) Biological tests and assays. In: The US. Pharmacopeia, 22nd revision. Rockville, MD: U.S. Pharmacopeial Convention Inc., 1488-1513.
9. 9. U.S. General Services Administration (1993) Biological tests and assays. In: Code of Federal Regulations. Title 21, 4-1-93 edn. Washington: U.S. General Services Administration, National Archives and Records Service, Office of the Federal Register, US. Govt. Print. Office, 328-344.
10. 10. Tenjarla SN, Allen R, Mitchell B. (1995) High performance liquid chromatographic assay of terbutaline for pre-formulation studies. Journal of Liquid Chromatography, 18(8), 1603-1615.
11. 11. Sternson LA, Patton TF, King TB. (1982) High performance liquid chromatographic analysis of miconazole in plasma. Journal of Chromatography, 227, 223-228.
12. 12. Tenjarla SN, Tesggai A. (1992) High performance liquid chromatographic assay of prazosin for transdermal screening. Journal of Clinical Pharmacy and Therapeutics, 17, 37-42.
13. 13. Tenjarla SNA, Uen R, Borazani A. (1994) Evaluation of verapamil hydrochloride permeation through human cadaver skin. Drug Development and Industrial Pharmacy, 20, 59-63.
14. 14. Heel RC, (1980) Miconazole. Drug Intelligence Clinical Pharmacy, 14, 80-95.
15. 15. Stranz MH, (1980) Miconazole: a preliminary review of therapeutic efficacy in systemic fungal infections. Drug, 19, 7-30.